Orient Europharma Co., Ltd.(TW:4120)
NT$44.35+2.30 (+4.85%)
TW:4120
Orient Europharma Co., Ltd. financials statements
NT$44.35
At close:+2.30 (+4.85%)
Orient Europharma Co., Ltd. (4120) Ratios
Orient Europharma Co., Ltd. Ratios
TW:4120's free cash flow for Q2 2026 was NT$-376.10M. For the 2026 fiscal year, TW:4120's free cash flow was decreased by NT$-71.50M and operating cash flow was NT$-304.61M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.47 | 1.20 | 1.14 | 1.10 | 1.21 |
| Quick Ratio | 1.10 | 0.89 | 0.84 | 0.77 | 0.90 |
| Cash Ratio | 0.68 | 0.43 | 0.47 | 0.47 | 0.61 |
| Solvency Ratio | -0.08 | -0.01 | 0.05 | -0.02 | 0.05 |
| Operating Cash Flow Ratio | -0.10 | -0.04 | 0.03 | -0.06 | 0.02 |
| Short-Term Operating Cash Flow Coverage | -0.15 | -0.05 | 0.05 | -0.09 | 0.03 |
| Net Current Asset Value | NT$ -556.27M | NT$ -1.77B | NT$ -2.42B | NT$ -2.80B | NT$ -2.03B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.37 | 0.45 | 0.48 | 0.45 |
| Debt-to-Equity Ratio | 0.52 | 0.82 | 1.38 | 1.72 | 1.44 |
| Debt-to-Capital Ratio | 0.34 | 0.45 | 0.58 | 0.63 | 0.59 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.21 | 0.34 | 0.40 | 0.36 |
| Financial Leverage Ratio | 1.94 | 2.24 | 3.08 | 3.56 | 3.20 |
| Debt Service Coverage Ratio | -0.16 | 0.03 | 0.19 | -0.00 | 0.05 |
| Interest Coverage Ratio | -4.19 | 0.12 | 0.80 | -3.72 | -1.52 |
| Debt to Market Cap | 0.76 | 0.92 | 1.30 | 1.44 | 1.26 |
| Interest Debt Per Share | 38.54 | 50.02 | 57.07 | 58.76 | 49.14 |
| Net Debt to EBITDA | -10.54 | 15.21 | 5.20 | -94.49 | 17.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 45.72% | 47.05% | 46.76% | 42.96% | 45.12% |
| EBIT Margin | -6.76% | -0.52% | 8.29% | -5.47% | 2.58% |
| EBITDA Margin | -2.65% | 4.19% | 13.00% | -0.72% | 2.80% |
| Operating Profit Margin | -6.76% | 0.30% | 1.84% | -5.48% | -1.21% |
| Pretax Profit Margin | -5.94% | -2.96% | 5.58% | -6.94% | 1.78% |
| Net Profit Margin | -12.35% | -6.47% | 3.13% | -6.57% | 2.52% |
| Continuous Operations Profit Margin | -10.45% | -5.26% | 3.69% | -6.24% | 1.96% |
| Net Income Per EBT | 207.81% | 218.43% | 56.17% | 94.72% | 141.77% |
| EBT Per EBIT | 87.92% | -975.53% | 303.07% | 126.69% | -146.74% |
| Return on Assets (ROA) | -4.65% | -2.45% | 1.33% | -2.98% | 1.28% |
| Return on Equity (ROE) | -9.02% | -5.50% | 4.10% | -10.61% | 4.09% |
| Return on Capital Employed (ROCE) | -3.34% | 0.16% | 1.19% | -3.90% | -0.94% |
| Return on Invested Capital (ROIC) | -2.74% | 0.12% | 0.57% | -2.53% | -0.60% |
| Return on Tangible Assets | -4.67% | -2.46% | 1.34% | -2.99% | 1.29% |
| Earnings Yield | -14.60% | -6.79% | 4.27% | -9.90% | 3.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.44 | 5.06 | 5.67 | 6.24 | 7.77 |
| Payables Turnover | 17.04 | 13.41 | 7.05 | 4.91 | 16.77 |
| Inventory Turnover | 2.30 | 2.25 | 2.23 | 2.12 | 2.55 |
| Fixed Asset Turnover | 1.17 | 1.13 | 1.14 | 1.15 | 1.11 |
| Asset Turnover | 0.38 | 0.38 | 0.42 | 0.45 | 0.51 |
| Working Capital Turnover Ratio | 4.48 | 7.42 | 10.12 | 8.72 | 3.69 |
| Cash Conversion Cycle | 204.64 | 207.03 | 176.20 | 156.02 | 168.52 |
| Days of Sales Outstanding | 67.07 | 72.17 | 64.38 | 58.50 | 46.98 |
| Days of Inventory Outstanding | 158.98 | 162.08 | 163.61 | 171.78 | 143.31 |
| Days of Payables Outstanding | 21.41 | 27.22 | 51.79 | 74.26 | 21.76 |
| Operating Cycle | 226.05 | 234.25 | 227.99 | 230.28 | 190.29 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.44 | -1.40 | 1.40 | -2.52 | 0.90 |
| Free Cash Flow Per Share | -5.44 | -2.55 | 0.23 | -9.91 | -17.18 |
| Dividend Paid and CapEx Coverage Ratio | -1.15 | -0.60 | 1.20 | -0.30 | 0.05 |
| Capital Expenditure Coverage Ratio | -1.72 | -1.21 | 1.20 | -0.34 | 0.05 |
| Operating Cash Flow Coverage Ratio | -0.09 | -0.03 | 0.02 | -0.04 | 0.02 |
| Operating Cash Flow to Sales Ratio | -0.06 | -0.03 | 0.03 | -0.05 | 0.02 |
| Free Cash Flow Yield | -12.15% | -5.29% | 0.60% | -27.38% | -47.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.85 | -14.74 | 23.43 | -10.11 | 26.15 |
| Price-to-Sales (P/S) Ratio | 0.85 | 0.95 | 0.73 | 0.66 | 0.66 |
| Price-to-Book (P/B) Ratio | 0.62 | 0.81 | 0.96 | 1.07 | 1.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.23 | -18.89 | 166.30 | -3.65 | -2.12 |
| Price-to-Operating Cash Flow Ratio | -13.01 | -34.52 | 27.88 | -14.36 | 40.61 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.05 | -0.16 | 0.03 | -0.66 |
| Enterprise Value Multiple | -42.46 | 37.94 | 10.86 | -186.45 | 40.65 |
| Enterprise Value | 5.17B | 6.98B | 6.48B | 6.37B | 5.42B |
| EV to EBITDA | -42.46 | 37.94 | 10.86 | -186.45 | 40.65 |
| EV to Sales | 1.13 | 1.59 | 1.41 | 1.35 | 1.14 |
| EV to Free Cash Flow | -10.95 | -31.53 | 319.45 | -7.40 | -3.64 |
| EV to Operating Cash Flow | -17.31 | -57.62 | 53.56 | -29.11 | 69.79 |
| Tangible Book Value Per Share | 84.17 | 66.64 | 47.51 | 39.20 | 38.91 |
| Shareholders’ Equity Per Share | 72.47 | 59.53 | 40.53 | 33.76 | 33.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.76 | -0.78 | 0.34 | 0.10 | 0.12 |
| Revenue Per Share | 52.97 | 50.62 | 52.96 | 54.53 | 54.95 |
| Net Income Per Share | -6.54 | -3.27 | 1.66 | -3.58 | 1.39 |
| Tax Burden | 2.08 | 2.18 | 0.56 | 0.95 | 1.42 |
| Interest Burden | 0.88 | 5.71 | 0.67 | 1.27 | 0.69 |
| Research & Development to Revenue | 0.12 | 0.06 | 0.04 | 0.05 | 0.07 |
| SG&A to Revenue | 0.43 | 0.41 | 0.41 | 0.41 | 0.40 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.53 | 0.93 | 0.84 | 0.67 | 0.92 |
Currency in TWD
